Tenax Therapeutics Announces Late-Breaking Presentation of LEVEL Clinical Trial Data at ESC Congress 2026

Data ReadoutNeutral

AI Analysis

Summary

Tenax Therapeutics announced a late-breaking presentation of LEVEL clinical trial data at ESC Congress 2026, with an abstract submitted in anticipation of initial data analysis.

Clinical Trial Data

Importance:5/10

Sentiment:

0.00

clinical_trialdata_presentationconference

Read the original article

Published by GlobeNewswire Clinical Studies on July 2, 2026 11:00 AM

Read Original